About Sebacia
Sebacia is a company based in Duluth (United States) founded in 2010. It operates as a B2B. Sebacia has raised $72.73 million across 10 funding rounds from investors including Hercules Capital, Square 1 Bank and Salem Partners. The company has 14 employees as of December 31, 2019. Sebacia operates in a competitive market with competitors including Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
- Headquarter Duluth, United States
- Employees 14 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sebacia, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$72.73 M (USD)
in 10 rounds
-
Latest Funding Round
$10 M (USD), Series D
Sep 13, 2019
-
Investors
Hercules Capital
& 6 more
-
Employee Count
14
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sebacia
Sebacia has successfully raised a total of $72.73M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sebacia
Sebacia has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hercules Capital, Square 1 Bank and Salem Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Locked | Locked | Locked |
Investor details for Sebacia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sebacia
Investment portfolio details for Sebacia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sebacia
Detailed financials for Sebacia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sebacia Comparisons
Peer comparison for Sebacia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sebacia
Sebacia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive energy device for hyperhidrosis treatment is provided.
|
|
| Locked | Locked | Locked |
Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections
|
|
| Locked | Locked | Locked |
Offers coal tar and light combination therapy for effective psoriasis treatment.
|
|
| Locked | Locked | Locked |
Nanoparticle-based products for cosmetics and health sectors are developed.
|
|
| Locked | Locked | Locked |
Sells devices for fat reduction, body shaping, and skin firming online.
|
Detailed competitors of Sebacia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sebacia
Complete news archive for Sebacia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sebacia
Sebacia was founded in 2010.
Sebacia is headquartered in Duluth, United States.
Sebacia is a funded company, having raised a total of $72.73M across 10 funding rounds to date.
As of Dec 31, 2019, the latest employee count at Sebacia is 14.
Sebacia develops topical microparticle therapies for dermatological conditions through providing healthcare solutions, producing pharmaceutical products, dermatology, and topical therapies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sebacia's top competitors include Candesant, PhotoSonix Medical and Nano Ceuticals.
Sebacia has 7 investors. Key investors include Hercules Capital, Square 1 Bank, Salem Partners, Versant Ventures, and Domain Associates.